Xerient Pharma
PrivateLast Round
Seed
Feb 1, 2025
Total Funding Raised
$4.17M
Company Overview
Xerient Pharma is a drug discovery company that develops radioprotective therapeutics and diagnostics designed to enhance the effectiveness and safety of pancreatic cancer treatment.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Xerient Pharma Comparables
Compare Xerient Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Humanetics Corporation | 70% | |
| Galera Therapeutics | 66% | |
| Clinigen | 63% | |
Xerient Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Feb 1, 2025 | ||||
| Seed | Jul 1, 2023 | ||||
| Grant | Jan 19, 2023 | ||||
| Grant | Aug 17, 2022 | ||||
| Seed | Mar 30, 2020 |
Xerient Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BIRD Foundation | Grant |
| Southern Israel Bridging Fund | Seed |
| NewTech Investment Holdings | Seed |
| Peregrine Ventures | Seed |
| Incentive Incubator | Seed |
| Cancer Prevention and Research Institute of Texas | Grant |
Xerient Pharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Xerient Pharma's valuation, stock price, and market status.